LATEST NEWS

EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel

EXACT Therapeutics announces first half 2023 interim results

EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development

EXACT Therapeutics announces positive clinical results from the ACTIVATE Phase I dose escalation
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer